Implantable Loop Recorders Market Size, Share & Trends Analysis Report By Activation (Automatic, Manual), By Application (Atrial Fibrillation, Cardiac Arrhythmia), By End Use (Hospitals, Cardiac Centers), By Region, And Segment Forecasts, 2025 - 2030

Implantable Loop Recorders Market Trends

The global implantable loop recorders market size was estimated at USD 1.55 billion in 2024 and is projected to grow at a CAGR of 10.1% from 2025 to 2030. The increasing incidence rate of cardiovascular disorders, technological advancements, and growing demand for remote patient monitoring are some of the factors propelling the market growth. Moreover, physical inactivity due to a sedentary lifestyle increases the risk of developing chronic cardiac conditions, which is further expected to drive market growth. In May 2024, an article in Open Heart reported on a study analyzing rhythm monitoring strategies in over 48,000 patients with ischemic or cryptogenic stroke. The research found that implantable loop recorders (ILRs) led to a higher diagnosis rate of atrial fibrillation and initiation of oral anticoagulation, but no difference in mortality compared to long-term continuous external monitors. ILRs also incurred significantly higher costs. 

The increasing incidence of heart diseases, particularly arrhythmias, is a major driver for the implantable loop recorders market.In October 2024, the CDC reported that heart disease is the primary cause of death among men, women, and individuals from various racial and ethnic backgrounds. Cardiovascular disease claims a life every 33 seconds. As the population ages, the need for continuous heart monitoring grows. ILRs offer an effective solution to detect irregular heart rhythms over extended periods. This growing demand is pushing healthcare providers to adopt these devices for early detection and personalized treatment. As a result, ILRs have become an essential tool in managing chronic heart conditions.

Technological improvements have significantly enhanced the functionality of implantable loop recorders. Newer devices are more compact, energy-efficient, and capable of providing more accurate data. These advancements also ensure longer device life and better patient comfort. Furthermore, wireless connectivity allows real-time monitoring and easy transmission of data to healthcare providers. In May 2024, Medtronic revealed that it has implemented artificial intelligence in all Reveal LINQ ICM devices across the U.S., Australia, and New Zealand through a cloud-based upgrade. The introduction of AccuRhythm AI algorithms is projected to decrease false alerts by 85%, while still maintaining high true alert rates. This enhancement enables clinics to save more than 186 hours each year for every 200 patients, allowing healthcare providers to focus on more essential patient care tasks.

The shift towards minimally invasive procedures is another key driver for the growth of the ILR market. These devices offer an effective means of continuous heart monitoring without the need for frequent hospital visits or open surgeries. The small size and ease of implantation reduce risks and recovery time for patients. With a growing preference for less invasive diagnostic methods, ILRs present an ideal solution for ongoing heart condition management. This trend is expected to continue to fuel market growth. In October 2024, an article in Biosensors highlighted the importance of wearable devices in managing cardiovascular diseases. These devices provide continuous real-time monitoring and are categorized by technologies such as galvanic contact and photoplethysmography.

Market Concentration & Characteristics

The degree of innovation in the implantable loop recorders industry is high, driven by continuous advancements in device miniaturization, battery life, and remote monitoring capabilities are enhancing the usability and effectiveness of ILRs. Improvements in data analytics and integration with mobile health applications are increasing the diagnostic potential of these devices. This innovative trend is expected to drive the market forward, meeting the evolving needs of cardiac care. In September 2024, a study in the European Heart Journal Open revealed that patients with embolic stroke of undetermined source had a significantly higher incidence of atrial fibrillation (AF) detected by implantable loop recorders (48.6% vs. 13.8%).

The level of mergers and acquisitions in the implantable loop recorders industry is medium. Companies are seeking to expand their product portfolios, enter new markets, and enhance their technological capabilities. This has led to strategic acquisitions by major players to strengthen their position in the growing market for cardiac monitoring devices. M&A activities are expected to continue as competition intensifies and companies aim to diversify their offerings. 

Regulations play a significant role in the implantable loop recorders industry, and their impact is high. As medical devices, ILRs must comply with stringent regulatory standards, such as those set by the FDA in the U.S. and the European Medicines Agency (EMA). These regulations ensure safety and effectiveness but also influence the speed at which new products can be brought to market and the cost of development. Manufacturers must navigate these complex regulatory environments to ensure timely market entry.

Product expansion in the implantable loop recorders industry is high. Manufacturers are increasingly focusing on expanding their product lines with advanced features like enhanced data connectivity, longer-lasting devices, and improved patient monitoring solutions. This expansion is aimed at providing comprehensive cardiac care solutions for a wider range of patients. It is also expected to foster greater patient engagement through continuous monitoring and personalized care options.

Regional expansion in the implantable loop recorders industry is medium. While North America and Europe are the primary markets for ILRs due to high healthcare standards, there is growing demand in Asia Pacific and Latin America. As healthcare infrastructure improves in these regions, manufacturers are focusing on expanding their presence to tap into new opportunities. This regional expansion is expected to be a key driver of market growth in emerging economies. 

Activation Insights

The automatic recorders segment held the largest market share of 60.6% in 2024 and is anticipated to grow at the fastest CAGR over the forecast period. Automatic recorders are devices designed to continuously monitor and record the electrical activity of the heart without requiring manual intervention. These devices are typically used for long-term monitoring of patients with arrhythmias, ensuring consistent and accurate data collection over extended periods. Their ability to autonomously trigger recording during abnormal heart rhythms makes them crucial in detecting intermittent arrhythmias. On October 2023, a study published in EP Europace evaluated the use of implantable loop recorders (ILRs) for continuous rhythm monitoring in patients with systemic right ventricles following atrial switch repair. Out of 24 patients, significant arrhythmias were detected in 63% of the cohort, leading to changes in medication and device therapy recommendations.

The manual recorders segment is expected to grow at a significant rate during the forecast period. Manual recorders require healthcare professionals to initiate and manage the data collection process. These devices are commonly used in clinical settings where more direct, temporary heart monitoring is needed. They offer flexibility but may not provide the continuous monitoring capabilities of automatic recorders, making them more suitable for short-term diagnostic use. In January 2024, an article in EP Europace evaluated an AI-based ILR-ECG Analyzer for improving the diagnostic accuracy of insertable cardiac monitors (ICM), which capture episodes activated manually by patients during symptomatic events. The algorithm effectively reclassified many abnormal diagnoses, potentially easing the clinical workload of reviewing ICM events.

Application Insights

The atrial fibrillation segment held the largest market share of 41.8% in 2024 and is expected to grow at the fastest CAGR of 10.9% during the forecast period. Atrial fibrillation (AF) is a prevalent arrhythmia characterized by irregular and frequently rapid contractions of the heart's upper chambers. This condition carries risks of complications like stroke and heart failure, making accurate detection and monitoring essential for effective management and treatment. In August 2024, the European Journal of Pediatrics highlighted a study on implantable loop recorders (ILRs) in diagnosing pediatric arrhythmias, including atrial fibrillation. The study found a diagnostic yield of 60% in symptom-activated cases and showed that 80% of diagnosed patients received targeted management, indicating ILRs' effectiveness and safety.

The cardiac syncope segment is the second largest segment in the implantable loop recorders market. Cardiac syncope refers to fainting episodes caused by irregular heart rhythms or cardiac conditions. Implantable loop recorders are commonly used to monitor patients who experience unexplained syncope, helping to identify the underlying cause of the episodes and guide treatment strategies. In June 2024, the European Heart Journal reported that implantable loop recorders (ILRs) effectively diagnosed cardiac issues in 871 patients. The study found ILRs established diagnoses in 31% of presyncope/syncope cases and altered treatment strategies in nearly 26% of these patients, underscoring their value in managing unexplained cardiac symptoms.

End Use Insights

The hospitals segment held the largest market share of 58.9% in 2024. Hospitals are primary locations for the use of implantable loop recorders, where patients with suspected arrhythmias or unexplained heart issues are monitored. The devices are critical for diagnosing conditions that require long-term observation, particularly in emergency and critical care units. Hospitals provide the specialized care and resources needed for implanting and managing these devices. In September 2024, an article in Age and Ageing discussed a hospital in Ireland that has provided an Implantable Loop Recorder (ILR) service for embolic strokes of undetermined source (ESUS) since 2017. Out of 58 implants, atrial fibrillation was detected in 29.3% of cases. The findings indicate that the ILR service requires around 2 hours of consultant time per case, with an expected implantation rate of 8-10% of all infarcts. 

The cardiac centers segment is the fastest-growing application in the implantable loop recorders market. Cardiac centers specialize in diagnosing and treating heart conditions, including arrhythmias. These centers use advanced diagnostic tools like implantable loop recorders to monitor patients with long-term heart conditions, offering more precise and continuous tracking for accurate diagnosis and treatment planning. Their expertise helps ensure optimal patient management through detailed heart rhythm monitoring. In May 2022, an article in EP Europace discussed a study from three cardiac centers in Germany assessing patient attitudes toward remote monitoring of implanted devices. Conducted from July to November 2021, the survey of 617 patients revealed strong acceptance, with 84.9% managing remote monitoring independently and 44.0% reporting improved disease management. Many patients preferred smartphone applications for this purpose.

Regional Insights

Implantable loop recorders market in North America dominated with a revenue share of 36.8% in 2024 due to the increasing prevalence of cardiovascular diseases and a rising aging population. The U.S. has been a leader in adopting advanced medical technologies, making it a key region for ILRs, with ongoing innovation in heart monitoring. Healthcare providers in the region are increasingly integrating these devices into standard cardiac care practices. In June 2024, Upstate Medical University's Cryptogenic Stroke team improved patient care by implanting Medtronic Insertable Cardiac Monitors to detect atrial fibrillation (AFib). With a team of six trained clinicians now performing the procedure, patient outcomes have improved, enabling earlier diagnosis and better treatment for stroke patients.

U.S. Implantable Loop Recorders Market Trends

The U.S. implantable loop recorders market is one of the largest globally, driven by the increasing rates of arrhythmias and other cardiac conditions. The adoption of ILRs is also fueled by advancements in minimally invasive procedures, offering patients a more convenient and effective solution for continuous heart monitoring. U.S. healthcare systems are increasingly adopting these devices for both outpatient and inpatient care. In April 2024, a study revealed that ischemic stroke patients monitored with mobile cardiac outpatient telemetry (MCOT) had lower readmission rates (30.2%) and healthcare costs (USD 27,429 less) compared to those using implantable loop recorders (ILR) (35.4%).

Europe Implantable Loop Recorders Market Trends

The implantable loop recorders market in Europe represents a significant market for implantable loop recorders, with key players offering advanced devices. The rise in cardiovascular diseases, along with growing healthcare awareness, is contributing to market growth. In addition, strong healthcare infrastructures and regulatory support are bolstering the demand for ILRs across various European nations. In May 2024, a study in the Hellenic Journal of Cardiology highlighted the effectiveness of Implantable Loop Recorders (ILRs) in diagnosing cardiac issues among 871 patients. The ILRs diagnosed 31% of those with presyncope/syncope, 22% of patients with palpitations, and 19.5% of cryptogenic stroke cases, significantly influencing treatment strategies for nearly a quarter of the patients.

Implantable loop recorders market in the UK is driven by increasing arrhythmia diagnoses and the preference for minimally invasive monitoring devices. The National Health Service (NHS) has also been integrating ILRs as part of broader efforts to enhance heart disease management in the population. Continued research and development are likely to lead to further adoption of ILRs in the country. In March 2024, an article in Heart Rhythm O2 highlighted the current guidelines for implantable loop recorder (ILR) explantation, recommending the procedure upon battery depletion or after diagnosis, while considering patient preferences. It noted that ILR localization can be unreliable in patients with a high body mass index, often requiring fluoroscopy.

Germany implantable loop recorders market is driven by its advanced healthcare system and high demand for cardiac monitoring solutions. Innovations in medical devices and growing awareness of arrhythmias are further driving market growth in the country. The market is expected to be supported by Germany's strong regulatory frameworks and investment in healthcare technologies. In May 2024, an article published in the journal EP Europace evaluated 388 patients in Germany with implantable loop recorders (ILRs). The study found that 79.2% detected arrhythmias after 12 months, and ILRs led to new therapies or medication changes in 58.8% of cases, highlighting their diagnostic value.

Asia Pacific Implantable Loop Recorders Market Trends

The Asia Pacific region is rapidly expanding in the implantable loop recorders market, driven by rising cardiovascular disease rates and increased healthcare access in countries like China, Japan, and India. Technological advancements and improvements in healthcare infrastructure are also contributing to this growth. In June 2024, an article in Cardiovascular Therapeutics highlighted those cardiovascular diseases (CVDs) affect Indians at least 10 years earlier than Europeans, impacting them during their most productive midlife years. CVDs were the leading cause of death in India, accounting for 31.8% of all deaths and 14.7% of disability-adjusted life years (DALYs) globally in 2017. 

Implantable loop recorders market in China is growing due to as healthcare services continue to improve, particularly in urban areas. The growing prevalence of heart diseases, coupled with increasing government support for healthcare technology, is boosting the market for ILRs. The country's large population and rising healthcare investments are expected to further accelerate adoption. In October 2024, an article in Thrombosis and Haemostasis discussed updated guidelines from the Geriatric Society of Chinese Medical Association on managing atrial fibrillation (AF) in the elderly. Originally published in 2011 and updated in 2016, the new consensus emphasizes AF screening, comprehensive geriatric assessment, the ABC pathway, and the use of smart technology in treatment.

Japan implantable loop recorders market is a well-developed healthcare system and the aging population, which contributes to a higher prevalence of heart conditions. The country has also seen an increase in demand for minimally invasive medical technologies, further supporting ILR adoption. Japan’s healthcare sector is likely to continue prioritizing advancements in heart disease diagnosis and management. In October 2024, the Journal of the American Heart Association published an article examining atrial fibrillation (AF) incidence in patients with cryptogenic stroke via the Reveal LINQ Registry. Of the 271 patients globally, 28.2% were found to have AF within 36 months.

Latin America Implantable Loop Recorders Market Trends

In Latin America, implantable loop recorders market, Brazil is driving the adoption due to growing healthcare investments and the increasing burden of cardiovascular diseases in the region. Key countries like Brazil and Argentina are experiencing heightened demand for advanced cardiac monitoring technologies. The expansion of healthcare facilities and growing awareness are driving the market forward. In June 2024, an article published in Heart and Mind discussed the importance of anticoagulation therapy for patients with left ventricular noncompaction cardiomyopathy (LVNC) who have had embolic events, atrial fibrillation (AF), left ventricular thrombus, or severe dysfunction.

Brazil implantable loop recorders market is agrowing healthcare sector due to the adoption of implantable loop recorders. Growing awareness of cardiovascular diseases and increasing healthcare investments are driving market demand. Brazil’s expanding healthcare infrastructure also supports the broader use of advanced cardiac monitoring solutions, providing patients with more options for heart disease management. In October 2024, an article published in Communications Medicine discussed the potential of mobile and sensor technologies for personalized health management, particularly in diagnosing and managing cardiac arrhythmias. Brazil's National Health Surveillance Agency (ANVISA) had been updating its regulatory framework to adapt to these digital health innovations.

Middle East and Africa Implantable Loop Recorders Market Trends

The Middle East and Africa’s markets are experiencing growing demand for implantable loop recorders. Rising heart disease rates, combined with improvements in healthcare infrastructure, are fueling demand for advanced cardiac monitoring devices in these regions. In February 2024, Rashid Hospital and Tawam Hospital made history as the first two hospitals in the UAE to enroll in the American Heart Association’s Get with The Guidelines- Heart Failure program. This program aims to improve the quality of life for heart failure patients by helping them spend more healthy days at home. In the MENA region, around 3.75 million people are affected by heart failure, a condition that indicates the heart struggles to effectively pump blood and oxygen throughout the body.

The market for implantable loop recorders in Saudi Arabia is expanding due to the growing prevalence of cardiac diseases and the country’s focus on advancing healthcare technology. In March 2024, a BMC Cardiovascular Disorders article reported that the prevalence of cardiovascular diseases (CVDs) among Saudis aged 15 and older is 1.6%, with a total of 236,815 cases. The rates are higher in males at 1.9% compared to 1.4% in females. Investments in healthcare and a rising awareness of arrhythmias are contributing to the market's growth in the region. Saudi Arabia’s healthcare modernization is expected to drive further adoption of ILRs.

Key Implantable Loop Recorders Company Insights 

Some of the key market players operating in the implantable loop recorders market include Medtronic, Biotronik and Abbott. These companies are making significant infrastructure investments, which enable them to develop, manufacture, and commercialize a high volume of recorders worldwide. In addition, to increase their presence globally, companies engage in several strategic partnerships with distributors and other companies.

Recent Developments

• In November 2024, Boston Scientific Corporation declared that it will acquire Cortex, Inc., a medical technology firm specializing in a diagnostic mapping solution aimed at pinpointing triggers of atrial fibrillation, a heart rhythm condition that impacts around 38 million individuals globally.

• In November 2024, a study published in Heart Rhythm demonstrated that AI algorithms in Medtronic's LINQ II implantable loop recorders lead to a 20% reduction in alert burdens and a 40% decrease in episode burdens. These algorithms effectively filter out false positives before reaching healthcare providers, enhancing the efficiency of remote cardiac monitoring with data sourced from 26 healthcare centers across the U.S.

• In October 2024, RAK Hospital led initiatives to address the increased risk of fatal heart attacks and strokes in diabetics with Silent Angina. During the RAK Diabetes Challenge 2024, the hospital emphasized the crucial connection between diabetes and heart health, highlighting the importance of preventive strategies to reduce cardiovascular complications among diabetic patients.

• In July 2024, Boston Scientific Corporation introduced a digital solution that improves cardiac care access in remote areas like the Azores and South Africa. This technology ensures reliable connections to global experts, enhancing critical cardiac procedures despite geographical challenges.

• In February 2024, an article in the Journal of the American Heart Association examined the use of implantable loop recorders (ILRs) with artificial intelligence algorithms to reduce false positive alerts. The study reviewed 117 LINQII and LUX-Dx patients monitored between March and June 2022, finding that AI-enhanced ILRs significantly decreased false positives and alert burdens without missing critical arrhythmias, highlighting their potential utility in clinical practice. 

Implantable Loop Recorders Market Report Scope 

Global Implantable Loop Recorders Market Report Segmentation

This report forecasts revenue growth at global, regional and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2018 to 2030. For this study, Grand View Research has segmented the global implantable loop recorders market report based on activation, application, end use, and region:

• Activation Outlook (Revenue, USD Million, 2018 - 2030)

  • Automatic Recorders

  • Manual Recorders

• Application Outlook (Revenue, USD Million, 2018 - 2030)

  • Atrial Fibrillation

  • Cardiac Arrythmia

  • Cardiac Syncope

• End Use Outlook (Revenue, USD Million, 2018 - 2030)

  • Hospitals

  • Cardiac Centers

  • Others

• Regional Outlook (Revenue, USD Million, 2018 - 2030)

  • North America

    • U.S.

    • Canada

    • Mexico

  • Europe

    • UK

    • Germany

    • France

    • Italy

    • Spain

    • Denmark

    • Sweden

    • Norway

  • Asia Pacific

    • Japan

    • China

    • India

    • South Korea

    • Australia

    • Thailand

  • Latin America

    • Brazil

    • Argentina

  • Middle East & Africa

    • South Africa

    • Saudi Arabia

    • UAE

    • Kuwait